Companies: 10,795·Total market cap: $144.5T

Rein Therapeutics Inc.

Rein Therapeutics Inc.

RNTXNASDAQHealthcare● Active

$0.95

+$0.01(+0.59%)

Market Cap$26521833

P/E Ratio—

52W High$2.18

52W Low$0.915

Avg Volume593K

Open$0.96

Beta1.35

股票排行：Medical - Pharmaceuticals·Healthcare·查看全部市值排行 →

Rein Therapeutics Inc.（RNTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · RNTX · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.90Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding25.4MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 Rein Therapeutics Inc. 数据

分析师预测$6 · Buy

股息不分红

盈利EPS $-1.96+44.16%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$49.9M▲ +20.69% YoY

202320242025

FY 2025EPS$-1.96▲ +44.16% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$50.2MEPS: $-1.90View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

1

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$6.00Low

$0.95Current

$6.00Avg Target上涨空间 532.44%

$6.00High

合计: 2 · 买入占比: 50.0%

根据过去 3 个月内 2 位华尔街分析师，RNTX 共识评级为 Buy，12 个月平均目标价 $6.00 （较现价 $0.95 上涨空间 532.44%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Rein Therapeutics Inc.

$0.95+0.59%$26.5M #2

Actinium Pharmaceuticals, Inc.

$1.06-1.85%$33.3M #3

$3.31-0.60%$4.2M #4

HeartBeam, Inc.

$0.81-3.44%$27.9M #5

Celularity Inc.

$0.81-6.92%$19.5M #6

Kezar Life Sciences, Inc.

$7.29+0.00%$53.9M

股票表现

1D+0.59%

1W-6.07%

1M-22.24%

3M-20.94%

YTD-18.22%

1Y-52.09%

5Y-55.25%

关于 Rein Therapeutics Inc.

CEOJames Brian Windsor

IPO DateJun 29, 2017

Employees11

CountryUS

Websitereintx.com

Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The c…

Medical - Pharmaceuticals HealthcareNASDAQUS

关于股票概览与关键数据

Rein Therapeutics Inc.（RNTX）是 Medical - Pharmaceuticals 行业的 Healthcare 类公司，于 Jun 29, 2017 在 NASDAQ 上市。截至最近交易日，RNTX 股价为 $0.95，市值约为 $26.5M。过去12个月累计回报 -52.09%，年初至今回报 -18.22%。

根据 2 位华尔街分析师，Rein Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $6.00。2025 财年 Rein Therapeutics Inc. 营收 —，净利润 -$49.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Rein Therapeutics Inc.（RNTX）股价为 $0.95，在 NASDAQ 上市，52周区间为 $0.92 – $2.18。

RNTX 最新股价RNTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议